Evidence map›Paper›PMID 39960548›Full record

ArticleCell and tissue research2025

Identification of glutamate-related disease-dependent alterations in subventricular NSCs of the 3xTg Alzheimer's disease model, could they be involved in attempting damage repair?

Giorgia Cerqueni, Valentina Terenzi, Alessandra Preziuso, Tiziano Serfilippi, Silvia Piccirillo, Mariangela Di Vincenzo, Patrizia Ambrogini, Salvatore Amoroso, Monia Orciani, Vincenzo Lariccia and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cell and tissue research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giorgia Cerqueni *Department of Biomedical Sciences and Public Health, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy. g.cerqueni@staff.univpm.it.ORCID http://orcid.org/0000-0001-7390-7154
Valentina Terenzi *Department of Biomedical Sciences and Public Health, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy.ORCID http://orcid.org/0009-0001-1392-1023
Alessandra PreziusoDepartment of Biomedical Sciences and Public Health, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy.ORCID http://orcid.org/0000-0001-9721-2023
Tiziano SerfilippiDepartment of Biomedical Sciences and Public Health, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy.ORCID http://orcid.org/0009-0002-5516-1023
Silvia PiccirilloDepartment of Biomedical Sciences and Public Health, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy.ORCID http://orcid.org/0009-0004-7608-5589
Mariangela Di VincenzoDepartment of Clinical and Molecular Sciences, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy.ORCID http://orcid.org/0000-0003-1289-7946
Patrizia AmbroginiDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Via Ca' Le Suore 2-4, 61029, Urbino, PU, Italy.ORCID http://orcid.org/0000-0002-3195-0725
Salvatore AmorosoDepartment of Biomedical Sciences and Public Health, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy.
Monia OrcianiDepartment of Clinical and Molecular Sciences, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy. m.orciani@staff.univpm.it.ORCID http://orcid.org/0000-0003-4503-3693
Vincenzo Lariccia *Department of Biomedical Sciences and Public Health, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy.ORCID http://orcid.org/0000-0002-1518-1495
Simona Magi *Department of Biomedical Sciences and Public Health, School of Medicine, Marche Polytechnic University, Via Tronto 10/A, 60126, Ancona, AN, Italy.ORCID http://orcid.org/0000-0002-8115-8226

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca (MIUR) 2022XF7XZFMinistero dell'Istruzione, dell'Università e della Ricerca (MIUR) 2022ZTKFXSRicerca Finalizzata Sanità Regione SardegnaRicerca Scientifica di Ateneo (RSA) 2022-2023
6 · The paper itself

Abstract

Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterised by several factors, such as impaired glutamate neurotransmission affecting crucial functions. Neural stem cells (NSCs) are present in the adult brains of all mammalian species and contribute to the continuous generation of neural cells throughout life. The disruption of glutamate levels during the development of AD could impact NSCs' functionality, influencing their response to the microenvironment. In this work, we isolated adult neural stem cells from both triple transgenic (3xTg)-AD mice and age-matched wild type (WT) mice in order to gather information on any differences between them, particularly concerning the potential mechanisms involved in the internalisation of glutamate and its utilisation for energy production. The 3xTg model offers the ability to recapitulate human pathology with both plaque and tangle hallmarks that are involved in the process of glutamate release. In vitro culture 3xTg NSCs showed a slight morphological difference compared to WT cells and a massive reduction of proliferation and viability. Furthermore, 3xTg NSCs displayed an increase in the expression of glutamate transporters and glutamine synthetase, while glutamate dehydrogenase did not show any reduction, which is typical in AD brains. Data obtained from this basic research study suggest a possible involvement of glutamate in the cellular energy balance, indicating an attempted response of NSCs to the cytotoxic microenvironment in the early stage of AD pathology. This finding is of great interest, as it corroborates the hypothesis that targeting the glutamatergic system could be an extremely promising strategy for new therapeutics in AD.

Indexed as

Alzheimer DiseaseGlutamic AcidLateral VentriclesNeural Stem CellsAnimalsCell ProliferationDisease Models, AnimalHumansMiceMice, TransgenicGlutamic Acid3xTgAlzheimer’s diseaseEnergy productionGlutamateNSCsTriple immunofluorescence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.